Skip to main content
OpenTrials
Completed

NCT Number: NCT03007017

Novel Strategies for Innovating Deceased Donor Procurement

Despite many efforts to increase the size of the donor pool, there is a large and growing disparity between the number of donor kidneys available for transplantation and the number of patients on the transplant waiting list. Increasing the quality of currently available donor kidneys would potentially improve the longevity of deceased donor kidney transplants by years, thus increasing the rate of transplantation patients on the kidney transplant waiting list. In addition, recipients of higher quality kidneys have shorter hospital stays and lower total hospital charges. By innovating the organ donation process, such that deceased donor kidneys are removed prior to the cessation of cardiac activity, rather than after, it may be possible to improve the quality of the kidney before transplantation, resulting in improved function after transplantation and increased longevity of these transplanted kidneys. Further, this improved kidney quality is highly likely to translate to reduced need for renal dialysis and other high-cost interventions, yielding lower total hospital charges. In this study we will test the hypothesis that, through a cost-free technical innovation, the quality of deceased donor kidneys could be improved significantly, saving thousands more lives per year and reducing total health care expenditures on renal transplantation.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Currently listed to receive a deceased donor kidney transplant
  • Able to fully understand the informed consent document
  • Recipient over the age of 18 years

Exclusion criteria

  • Recipients undergoing a bilateral native nephrectomy at time of transplant
  • Recipients undergoing dual (liver-kidney, kidney-pancreas, pediatric en bloc) transplant
  • Individuals who are unable to understand the informed consent document
  • Recipient under age 18 years
  • Recipients receiving desensitization protocols for high levels of donor specific antibodies

Treatment and study plan

Deceased donor nephrectomy, prior to cross clamp of donor aorta

Procedure

The investigators will perform a prospective investigation of organ recoveries during which the left kidney will be removed prior to cessation of cardiac activity. The second kidney will be removed in the standard fashion. To do this, investigators will adopt techniques used in living donor kidney transplantation. Specifically, a specialized vascular stapler will be used to divide the renal artery at the level of aorta, followed by the vein, at the level of the vena cava. As such, no "cuff" of abdominal aorta or vena cava will be present on the target kidneys. Once removed from the body, just as is done for living donor kidney transplantation, the kidneys will be immediately flushed. As this ex-vivo flush is already performed for cadaveric kidney transplantation, there should be no additional cost for performing this portion of the procedure. Approximately 15 minutes of additional surgical dissection (prior to stopping the heart) will be required under the proposed study.

Deceased donor nephrectomy, standard of care

Procedure

The investigators will remove the right kidney in the stand of care procedures for cadaveric kidney transplantation

Primary outcomes

  1. Sequence of organ procurement

    Time frame: 1 year

    Renal allograft survival

  2. Kidney quality

    Time frame: 3 months

    Incidence of delayed renal graft function

Sponsors and collaborators

Lead sponsor

University of Maryland, Baltimore

Other

Collaborators

  • Living Legacy Foundation

Registry information

Important dates

Study start
2017
Primary completion
2021
Study completion
2021
First posted
Dec 30, 2016
Registry last updated
Jun 9, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.